Loading...
Loading...
Pernix Therapeutics Holdings, Inc.
PTX, today announced it has entered into a license and
supply agreement with a private company for a new FDA-approved prescription
product to treat gastroenterology disease. Under the terms of the agreement,
Pernix obtained exclusive marketing rights to this gastroenterology product in
the United States.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in